Number and percentage of persons having been diagnosed with high blood pressure, by age group and sex.

In 2024, around 21.1 percent of Canadian adults reported that they had been diagnosed by a health professional as having high blood pressure. This statistic displays the estimated percentage of Canadians aged 18 years and over who reported being diagnosed with high blood pressure from 2015 to 2024.

This table contains 224448 series, with data for years 2003 - 2003 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (167 items: Health and Community Services St. John's Region; Newfoundland and Labrador; Health and Community Services Eastern Region; Newfoundland and Labrador; Newfoundland and Labrador; Canada ...) Age group (14 items: Total; 12 years and over; 12 to 14 years; 15 to 19 years; 12 to 19 years ...) Sex (3 items: Both sexes; Males; Females ...) High blood pressure (4 items: Total population for the variable high blood pressure; Without high blood pressure; High blood pressure; not stated; With high blood pressure ...) Characteristics (8 items: Number of persons; Coefficient of variation for number of persons; High 95% confidence interval; number of persons; Low 95% confidence interval; number of persons ...).

In 2017, around three percent of Aboriginal individuals in Canada aged 15 to 24 years reported having high blood pressure, compared to 40 percent of those aged 55 years and older. This statistic illustrates the percentage of Aboriginal individuals in Canada with self-reported long-term high blood pressure in 2017, by age.

This table contains 6720 series, with data for years 1994 - 1998 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (not all combinations are available): Geography (5 items: Territories; Yukon; Northwest Territories including Nunavut; Northwest Territories ...), Age group (14 items: Total; 12 years and over; 12-14 years; 15-19 years; 12-19 years ...), Sex (3 items: Both sexes; Females; Males ...), High blood pressure (4 items: Total population for the variable high blood pressure; Without high blood pressure; High blood pressure; not stated; With high blood pressure ...), Characteristics (8 items: Number of persons; Coefficient of variation for number of persons; Low 95% confidence interval - number of persons; High 95% confidence interval - number of persons ...).

This table contains 14784 series, with data for years 1994 - 1998 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (not all combinations are available): Geography (11 items: Canada; Newfoundland and Labrador; Prince Edward Island; Nova Scotia ...), Age group (14 items: Total; 12 years and over; 12-19 years; 15-19 years; 12-14 years ...), Sex (3 items: Both sexes; Males; Females ...), High blood pressure (4 items: Total population for the variable high blood pressure; Without high blood pressure; High blood pressure; not stated; With high blood pressure ...), Characteristics (8 items: Number of persons; High 95% confidence interval - number of persons; Coefficient of variation for number of persons; Low 95% confidence interval - number of persons ...).

This table contains 14784 series, with data for years 1994 - 1998 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (not all combinations are available): Geography (11 items: Canada; Newfoundland and Labrador; Prince Edward Island; Nova Scotia ...), Age group (14 items: Total; 12 years and over; 12-19 years; 15-19 years; 12-14 years ...), Sex (3 items: Both sexes; Males; Females ...), High blood pressure (4 items: Total population for the variable high blood pressure; Without high blood pressure; High blood pressure; not stated; With high blood pressure ...), Characteristics (8 items: Number of persons; High 95% confidence interval - number of persons; Coefficient of variation for number of persons; Low 95% confidence interval - number of persons ...).

This table contains 267456 series, with data for years 2000 - 2000 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (not all combinations are available): Geography (199 items: Canada; Newfoundland and Labrador; Health and Community Services St. John's Region; Newfoundland and Labrador (Peer group H); Health and Community Services Eastern Region; Newfoundland and Labrador (Peer group D) ...), Age group (14 items: Total; 12 years and over; 12-19 years; 12-14 years; 15-19 years ...), Sex (3 items: Both sexes; Females; Males ...), High blood pressure (4 items: Total population for the variable high blood pressure; High blood pressure; not stated; Without high blood pressure; With high blood pressure ...), Characteristics (8 items: Number of persons; Coefficient of variation for number of persons; High 95% confidence interval - number of persons; Low 95% confidence interval - number of persons ...).

This table contains 401184 series, with data for years 2000 - 2000 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (199 items: Canada; Newfoundland and Labrador; Health and Community Services Eastern Region; Newfoundland and Labrador (Peer group D);Health and Community Services St. John's Region; Newfoundland and Labrador (Peer group H) ...), Age group (14 items: Total; 12 years and over;12 to 19 years;15 to 19 years;12 to 14 years ...), Sex (3 items: Both sexes; Females; Males ...), Blood pressure check (6 items: Total; blood pressure check; Blood pressure check; within past 12 months; Blood pressure check; 2 or more years ago; Blood pressure check; 1 year to less than 2 years ago ...), Characteristics (8 items: Number of persons; Low 95% confidence interval; number of persons; Coefficient of variation for number of persons; High 95% confidence interval; number of persons ...).

High blood pressure, by age group and sex, household population aged 12 and over, territories

In 2017, around ** percent of First Nations people living off reserve in Canada had high blood pressure. This statistic illustrates the percentage of the indigenous population 50 years and older in Canada with select pre-existing health conditions as of 2017.

The National Population Health Survey (NPHS) is designed to collect information related to the health of the Canadian population. The first cycle of data collection began in 1994, and will continue every second year thereafter. The survey will collect not only cross-sectional information, but also data from a panel of individuals at two-year intervals.The target population of the NPHS includes household residents in all provinces, with the principal exclusion of populations on Indian Reserves, Canadian Forces Bases and some remote areas in Quebec and Ontario. Separate surveys were conducted to cover the Yukon, the Northwest Territories and the Institutions ( long term residents of hospitals and residential care facilities) and will be presented at a later stage.. The NPHS data are stored in four different data sets. Some information was collected from all household members. This information is stored in the General file. From each household, one person, aged 12 years and over, was selected to answer a more in-depth questionnaire related to health. These data are stored on the Health file. Each record on the General file corresponds to a household member. The General file carries the socio-demographic variables as well as health utilization variables. There are 58,439 records and 129 variables in the General file. The Health file contains 17,626 records and 439 variables.The Supplemental file is a subset of the health sample. Certain individuals in the Health sample were asked to answer supplemental questions. This file contains 13,400 records and 1023 variables.A special component of the program is a survey designed for people living in health care institutions, including hospitals, nursing homes, and residential facilities for persons with disabilities. This Institutional file contains data collected in 1995 from 2287 long-term residents of health care institutions in the provinces. Data between the files can be linked using the variable recno. Note: This data is also linked to the National Longitudinal Survey of Children

Canadian mean usual sodium intakes (mg/day)1 if all foods met Health Canada’s sodium reduction targets designed to meet population mean intake of 2,300 (mg/day) (Reformulation Scenario A), compared to sodium Dietary Reference Intake values, overall (n = 20,176)and by adult age/sex group (n = 13,612).

Snapshot img

Blood Pressure Cuffs Market - 2021-2025

The blood pressure cuffs market size is expected to reach a value of USD 127.06 million at a CAGR of 7.66%, during 2021-2025. This research study helps in a deep understanding of the underlying forces driving the market growth and current and potential target customers across segmentations. According to our comprehensive survey, factors such as increasing incidence of hypertension and growth of geriatric population are projected to significantly support market growth during the forecast period. View our sample report for insights on the latest trends and challenges that will have a far-reaching effect on the market growth.

To Unlock the Blood Pressure Cuffs Market Size for 2021 and Other Important Statistics Wait no Longer!

Complete the Payment and Get this Report Within a Minute!

Blood Pressure Cuffs Market Segments

Navigate through market segmentation by product (reusable cuffs and disposable cuffs) and geography (North America, Europe, Asia, and ROW) in this blood pressure cuffs market report to pursue growth opportunities.

Get actionable insights on the blood pressure cuffs market segments to generate successful ROIs and focus your business strategy efforts where they are most likely to be effective. Also, our market research experts have evaluated the impact of COVID-19 across market segments for our clients to understand the long-term business implications and foresee opportunities for subsequent recovery. Want a thorough qualitative and quantitative analysis on the post-pandemic blood pressure cuffs market predictions on-demand changes for 2021-2025? You can buy the report now with one easy click.

Blood Pressure Cuffs Market Vendors and Competitive Analysis

    The blood pressure cuffs market is fragmented and the vendors are deploying growth strategies such as focusing on product differentiation and distribution agreements to gain a competitive advantage. Find out about other well-thought-out business planning approaches of key players from our sample report.

    The unprecedented outbreak of COVID-19 last year impacted market segments that has had a ripple effect on various stakeholders. To make the most of the opportunities and recover from post COVID-19 impact, the market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Click here to get COVID-19 impact update.

    Buy the full blood pressure cuffs market forecast report for detailed insights on complete key vendor profiles. The profiles include information on the production, sustainability, prospects of the leading companies, and other crucial vendor landscape analysis.

Blood Pressure Cuffs Market - Region Opportunities 2021-2025

41% of the blood pressure cuffs market growth will originate from North America during the forecast period. The US and Canada are the key markets for blood pressure cuffs market in North America. To unlock exclusive information on potential business locations and understand the demographics of current and prospective customers buy the report now!

North America has been exhibiting a significant growth rate for blood pressure cuffs market vendors. Factors such as the increasing cases of high blood pressure or hypertension are accelerating the blood pressure cuffs market growth in North America. To view our in-depth analytical review on the micro and macroeconomic factors impacting businesses in the regions click here.

The blood pressure cuffs market share growth in North America will be slower than the growth of the market in Asia. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.

Blood Pressure Cuffs Market Insights by Product

To gain further insights on the market contribution of various segments Request for a FREE Sample!

The blood pressure cuffs market share growth by the reusable cuffs segment will be significant during the forecast period. The reusable cuffs market segment will be driven by its benefits such as durability, longevity and easy cleaning that will increase its demand in the market. This report provides an accurate prediction of the contribution of all the segments to the growth of the blood pressure cuffs market size.

From the blood pressure cuffs market segmentation insights, players can achieve maximum market response by understanding the target consumers. The analytical data on the segmentation will allow vendors to position their services and products among the right audiences and gain significant exposure and growth. Also, get updated actionable market insights on post COVID19 impact on each segment.

Blood Pressure Cuffs Market Drivers & Trends

While it is crucial to have a solid understanding of the drivers and trends, it is also imperative that the market challenges are recognized to improvize business pl

Snapshot img

Amlodipine Besylate Market Size 2024-2028

The amlodipine besylate market size is forecast to increase by USD 196.4 million at a CAGR of 3.3% between 2023 and 2028.

The market is experiencing significant growth, driven primarily by the rising incidence of hypertension worldwide. According to the World Health Organization, approximately 1.13 billion people globally live with hypertension, making it a major public health concern. Amlodipine Besylate, a calcium channel blocker, is a widely used medication in the treatment of hypertension and angina pectoris. Its effectiveness in managing these conditions has led to an increase in its usage, fueling market growth. However, the market is not without challenges. The potential side effects of Amlodipine Besylate on human health, such as headaches, dizziness, and peripheral edema, may limit its widespread adoption. Additionally, the presence of alternative treatments and generic drugs in the market may intensify competition and put pressure on market prices. Despite these challenges, the market presents significant opportunities for companies seeking to capitalize on the growing demand for effective hypertension treatments. Strategic collaborations, product innovation, and focus on improving patient safety and efficacy can help companies differentiate themselves in the market and maintain a competitive edge.

What will be the Size of the Amlodipine Besylate Market during the forecast period?

Request Free SampleThe market for amlodipine besylate, a calcium channel blocker commonly prescribed for conditions such as angina, aortic stenosis, and hypertension, including hypotension and edema, has experienced significant growth in the US. Oral solutions and suspensions, such as Norvasc and Norliqva, have gained popularity due to their ease of administration, particularly for patients experiencing stomach pain or allergies to oral tablets. The mechanism of action for amlodipine besylate involves relaxing the smooth muscles in blood vessels, leading to decreased blood pressure and improved blood flow. Storage requirements for amlodipine besylate are relatively straightforward, with room temperature being the recommended condition. However, it is essential that patients follow their healthcare provider's instructions regarding dosage forms and administration to ensure optimal therapeutic effects. Common side effects include dizziness, tiredness, and sleepiness. Less frequent side effects include nausea, flushing, and headache. Rare cases of heart attack, allergic reactions, and edema have been reported. Despite these side effects, the market for amlodipine besylate continues to grow, driven by its efficacy in managing cardiovascular conditions and the increasing prevalence of hypertension and related disorders in the US population. Over-the-counter (OTC) medicines for mild hypertension have not yet significantly impacted the prescription market for amlodipine besylate.

How is this Amlodipine Besylate Industry segmented?

The amlodipine besylate industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ApplicationHigh blood pressureHeart diseasesGeographyNorth AmericaUSCanadaEuropeGermanyUKAsiaChinaRest of World (ROW)

By Application Insights

The high blood pressure segment is estimated to witness significant growth during the forecast period.High blood pressure, a silent yet potentially dangerous condition, can cause damage to various organs if left untreated. This common health issue is characterized by increased force of blood against artery walls. If not managed effectively, high blood pressure can lead to severe health complications, including heart attack, heart failure, stroke, kidney failure, and vision loss. Amlodipine besylate, a calcium channel blocker, is a commonly prescribed medication to help control high blood pressure. It works by relaxing blood vessels, making it easier for the heart to pump blood and reducing the pressure on artery walls. Amlodipine is not only used to prevent angina (chest pain) but also to manage other conditions such as coronary artery disease, aortic stenosis, and hypertension. The medication is available in various dosage forms, including oral tablets and oral suspension, to cater to different patient needs. However, it's essential to note that amlodipine does not provide immediate relief from high blood pressure symptoms. It takes time for the medication to build up in your system and start working effectively. Common side effects include dizziness, flushing, and edema. Severe side effects like irregular heartbeat, allergic reactions, and pounding heartbeats require immediate medical attention. Patients taking amlodipine should be aware of potential drug interactions, such as those with alcohol, certain vitamins,

According to Cognitive Market Research, the global Blood Pressure Monitoring Devices Market size will be USD 4124.5 million in 2025. It will expand at a compound annual growth rate (CAGR) of 10.60% from 2025 to 2033.

North America held the major market share for more than 37% of the global revenue with a market size of USD 1526.07 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2033.
Europe accounted for a market share of over 29% of the global revenue with a market size of USD 1196.11 million.
APAC held a market share of around 24% of the global revenue with a market size of USD 989.88 million in 2025 and will grow at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2033.
South America has a market share of more than 3.8% of the global revenue with a market size of USD 156.73 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2033.
Middle East had a market share of around 4% of the global revenue and was estimated at a market size of USD 164.98 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2033.
Africa had a market share of around 2.2% of the global revenue and was estimated at a market size of USD 90.74 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.3% from 2025 to 2033.
Accessories is the fastest growing segment of the Blood Pressure Monitoring Devices Market industry

Market Dynamics of Blood Pressure Monitoring Devices Market

Key Drivers for Blood Pressure Monitoring Devices Market

The rising incidences of hypertension will boost the blood pressure monitoring devices market.

The rising prevalence of hypertension will drive the blood pressure monitoring device market. Hypertension, also known as high blood pressure, is a medical condition in which the force of blood against the artery walls is constantly elevated, resulting in increased pressure in the blood vessels. Blood pressure monitoring devices are used by healthcare providers and patients to improve their ability to manage hypertension and reduce the risk of related health complications. As a result, the market will benefit from the increased demand for accurate and dependable blood pressure monitoring devices for regularly monitoring and managing blood pressure levels. For instance, the World Health Organization, based in Switzerland, estimates that in March 2023, 1.28 billion adults aged 30-79 years will have hypertension, with the majority (two-thirds) living in low- and middle-income countries. As a result, rising hypertension rates are driving the expansion of the blood pressure monitoring device market

https://www.who.int/news-room/fact-sheets/detail/hypertension”/

Rising healthcare expenditures Boost Market Growth

Rising healthcare expenditures are expected to drive the future growth of the blood pressure monitoring device market. Healthcare expenditure is the total amount of money spent on healthcare-related goods and services within a specific healthcare system or economy. Healthcare spending is critical in promoting the development, availability, and use of blood pressure monitoring devices. For instance, according to the Canadian Institute for Health Information, a non-profit organization based in the United States, healthcare spending increased by 0.8% in November 2022, or $331 billion, from 7.6% in 2021. As a result, rising healthcare costs are driving the growth of the blood pressure monitoring device market

https://thehub.ca/2022/11/03/livio-di-matteo-total-health-spending-in-canada-will-reach-331b-this-year-driven-by-care-deferred-during-the-pandemic/”/

Restraint Factor for the Blood Pressure Monitoring Devices Market

High Cost of Advanced Devices Will Limit Market Growth

The high cost of advanced blood pressure monitoring machines is a major impediment to market expansion as it prevents many buyers from purchasing them. Most machines contain cutting-edge technology, such as wireless capabilities and sophisticated data analytics, which contributes to their high prices. As a result, individuals, particularly those with limited financial resources, may find it difficult to afford such costly alternatives. Customers may use less expensive, traditional monitoring techniques instead due to cost constraints, resulting in lower adoption rates. Furthermore, medical professionals may not recommend these devices du...

ObjectivesThe impact of concurrent adherence to antihypertensives, antidiabetics, and statins on cardiovascular disease (CVD) outcomes and intermediate clinical outcomes in people with hypertension and diabetes remains unclear. This study aimed to evaluate the association between medication adherence and CVD outcomes in such patients.MethodsThis retrospective cohort study analyzed the electronic medical records of 36,211 adults aged 18 or older diagnosed with hypertension and diabetes between January 2008 and June 2016 in Canada. Patients were prescribed antihypertensives, antidiabetics, and statins, with a minimum 1-year follow-up post-diagnosis. Medication adherence was determined by the proportion of days covered (PDC). For monotherapy, a PDC≥80% and

Healthcare Survey Dataset (Canada) – 2019-2020 Overview This dataset contains anonymized responses from the Canadian Health Survey (2019-2020), providing valuable insights into various health-related factors, lifestyle choices, and medical conditions of individuals across different provinces. It is a great resource for public health analysis, machine learning applications, and predictive modeling.

What’s Inside the Dataset? The dataset includes information on: - Demographics: Age, gender, marital status, household composition - Health Conditions: Chronic illnesses (diabetes, high blood pressure, sleep apnea, etc.) - Lifestyle Factors: Smoking, alcohol consumption, physical activity, food security - Mental Well-being: Stress levels, anxiety, mood disorders, life satisfaction - Healthcare Access: Insurance coverage, access to healthcare services - Employment & Work Stress: Work hours, job-related stress, income sources many more features

In 2024, Newfoundland and Labrador was the province with the highest prevalence of obesity among adults in Canada. At that time, around ** percent of adults in Newfoundland and Labrador were considered obese. However, Ontario was the province with the highest total number of obese adults, with over *** million adults suffering from obesity in 2024. What percentage of Canadians are obese? Obesity among adults in Canada has increased in recent years, reaching a high of ** percent in 2023, compared to a prevalence of around ** percent in 2015. That means in 2023, around **** million people in Canada were obese, while ***** million were considered overweight. There is not a huge difference in the prevalence of obesity among men and women in Canada; however, men in Canada are much more likely to be considered overweight than women. Being overweight or obese can increase a person’s chances of developing a number of health conditions, including high blood pressure, type 2 diabetes, and breathing problems such as asthma. Overweight and obesity among adolescents Overweight and obesity have also increased among adolescents in Canada in recent years. In 2022, around ** percent of adolescents in Canada aged 12 to 17 years were considered overweight or obese, compared to ** percent in the year 2005. Male adolescents in Canada are much more likely to be overweight or obese than their female counterparts. In 2022, around ** percent of adolescent males in Canada were overweight or obese, compared to ** percent of female adolescents. The provinces with the highest prevalence of overweight and obesity among adolescents are New Brunswick, Newfoundland and Labrador, and Prince Edward Island.

Canada Sodium Reduction Ingredients Market size was valued at USD 1.50 Billion in 2023 and is projected to reach USD 2.62 Billion by 2031, growing at a CAGR of 7.2% from 2024 to 2031.

Key Market Drivers:

Increasing Prevalence of Chronic Health Conditions: According to Health Canada, the prevalence of hypertension (high blood pressure) in Canada has increased from 17.1% in 2000-2001 to 22.6% in 2017-2018, affecting over 6 million Canadians. The Public Health Agency of Canada reports that 1 in 4 Canadian adults live with multiple chronic conditions, such as heart disease, stroke, diabetes, and chronic kidney disease, which are closely linked to high sodium intake. Government Initiatives and Regulations to Reduce Sodium Consumption: In 2010, Health Canada launched the Sodium Reduction Strategy for Canada, setting a target to reduce average sodium intake from 3400 mg/day to 2300 mg/day by 2016.